Open Access

Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma

  • Authors:
    • Yan Yang
    • Zhongyin Zhou
    • Rong Liu
    • Lu Chen
    • Hongyu Xiang
    • Na Chen
  • View Affiliations

  • Published online on: February 2, 2018     https://doi.org/10.3892/etm.2018.5831
  • Pages: 3259-3264
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) is an important treatment for inoperable hilar cholangiocarcinoma (HCC). The aim of the present study as to evaluate the clinical value of three‑dimensional visualization (3DV) and 3D printing (3DP) technologies for ERCP in patients with HCC. The clinical data of 15 patients with HCC admitted for ERCP were analyzed retrospectively, including 9 males and 6 females. Thin‑sliced data of computed tomography and magnetic resonance cholangiopancreatography (MRCP) were acquired and imported into Mimics Innovation Suite v17.0 software for 3D reconstruction. Standard Template Library files were exported for 3D printing. The target bile duct and Bismuth‑Corlette (BC) classification were selected and performed respectively with the aid of Mimics Innovation Suite v17.0 software. The results were compared with the selected ones in ERCP. 3DV and 3DP models were successfully constructed for all patients, which presented the tumor, bile duct and the spatial relationship between them from multiple perspectives. The ERCP of all patients in the present study were performed successfully. The target bile duct screened by them had a high concordance rate of 86.7% with that in ERCP. The diagnostic accuracy of BC type results by 3DV and 3DP models was 93.3%. 3DV and 3DP technologies can accurately show the tumor and its associations with the surrounding bile duct, and it can be used to guide ERCP in HCC patients and improve the success rate of the operation.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang Y, Zhou Z, Liu R, Chen L, Xiang H and Chen N: Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma. Exp Ther Med 15: 3259-3264, 2018
APA
Yang, Y., Zhou, Z., Liu, R., Chen, L., Xiang, H., & Chen, N. (2018). Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma. Experimental and Therapeutic Medicine, 15, 3259-3264. https://doi.org/10.3892/etm.2018.5831
MLA
Yang, Y., Zhou, Z., Liu, R., Chen, L., Xiang, H., Chen, N."Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma". Experimental and Therapeutic Medicine 15.4 (2018): 3259-3264.
Chicago
Yang, Y., Zhou, Z., Liu, R., Chen, L., Xiang, H., Chen, N."Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma". Experimental and Therapeutic Medicine 15, no. 4 (2018): 3259-3264. https://doi.org/10.3892/etm.2018.5831